EUVIMEDEUVIMED entdecken
Crossref

Drug treatment and incident sexually transmitted infections among people who use drugs: a prospective analysis of gender differences

Joy D Scheidell, Bedis Elkamel, Anne M Moore, Ariana Valentin, Jacob Bleasdale

American Journal of Epidemiology · 04.11.2026 · 195 (11) · 2695-2702

DOI: 10.1093/aje/kwag111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Epidemiology, online erschienen am 01.06.2026. Verfasst von Joy D Scheidell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, College of Health Professions and Sciences, University of Central Florida, Orlando, FL, United States. Hauptthemen laut MEDLINE: Sexually Transmitted Diseases, Substance-Related Disorders. Die Arbeit nennt 32 Literaturangaben. Gefördert von: the National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rates of bacterial sexually transmitted infections (STIs) and substance use–related harms have risen sharply in the United States, yet little is known about whether drug treatment affects STI risk among people who use drugs. We analyzed prospective data from 2142 participants who reported illicit drug use at baseline in Project AWARE recruited from 9 STI clinics nationwide. We examined associations between self-reported drug treatment in the past 6 months at baseline and biologically confirmed incident STI at 6-month follow-up, overall and by gender, using inverse probability of treatment weighting to estimate average treatment effects (ATE) and average treatment effects among the treated (ATT). At baseline, 14% reported drug treatment. In unadjusted models, drug treatment was associated with higher STI risk (RR = 1.43, 95% CI: 1.09, 1.88), driven by laboratory-identified infections. After weighting, the ATE was attenuated (RR = 1.37, 95% CI: 0.91, 2.07) and the ATT was null. Gender-stratified analyses suggested elevated STI risk among women in unadjusted models, but weighted estimates were nonsignificant, although clinically diagnosed STIs were less common among women in drug treatment. Findings indicate complex, gender-specific relationships between drug treatment and STI risk and underscore the need for integrated, gender-responsive STI prevention within drug treatment settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sexually Transmitted DiseasesSubstance-Related DisordersHumansProspective StudiesFemaleMaleUnited StatesAdultSex FactorsIncidenceRisk FactorsYoung Adult

Stichwörter der Autor:innen

drug treatmentgender differencesinverse probability of treatment weightingsexually transmitted infections

Autor:innen und Institutionen

  • Department of Health Sciences, College of Health Professions and Sciences, University of Central Florida, Orlando, FL, United States.
  • College of Arts and Science, New York University, New York, NY, United States.

Förderung

  • the National Institute on Drug Abuse

Zitieren

APA

Scheidell, J. D., Elkamel, B., Moore, A. M., Valentin, A., & Bleasdale, J. (2026). Drug treatment and incident sexually transmitted infections among people who use drugs: a prospective analysis of gender differences. American Journal of Epidemiology, 195(11), 2695-2702. https://doi.org/10.1093/aje/kwag111

Vancouver

Scheidell JD, Elkamel B, Moore AM, Valentin A, Bleasdale J. Drug treatment and incident sexually transmitted infections among people who use drugs: a prospective analysis of gender differences. American Journal of Epidemiology. 2026;195(11):2695-2702. doi:10.1093/aje/kwag111

BibTeX
@article{Scheidell2026,
  author = {Scheidell, Joy D and Elkamel, Bedis and Moore, Anne M and Valentin, Ariana and Bleasdale, Jacob},
  title = {Drug treatment and incident sexually transmitted infections among people who use drugs: a prospective analysis of gender differences},
  journal = {American Journal of Epidemiology},
  year = {2026},
  volume = {195},
  number = {11},
  pages = {2695--2702},
  doi = {10.1093/aje/kwag111}
}
Kostenlos starten →